HK1178804A1 - Improved methods and compositions for vein harvest and autografting - Google Patents
Improved methods and compositions for vein harvest and autograftingInfo
- Publication number
- HK1178804A1 HK1178804A1 HK13106474.7A HK13106474A HK1178804A1 HK 1178804 A1 HK1178804 A1 HK 1178804A1 HK 13106474 A HK13106474 A HK 13106474A HK 1178804 A1 HK1178804 A1 HK 1178804A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- autografting
- compositions
- improved methods
- vein harvest
- harvest
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0236—Mechanical aspects
- A01N1/0242—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components
- A01N1/0247—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components for perfusion, i.e. for circulating fluid through organs, blood vessels or other living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0278—Physical preservation processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Mechanical Engineering (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26764009P | 2009-12-08 | 2009-12-08 | |
PCT/US2010/059459 WO2011072012A2 (fr) | 2009-12-08 | 2010-12-08 | Procédés et compositions améliorés destinés au prélèvement de veines et à l'autogreffe |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1178804A1 true HK1178804A1 (en) | 2013-09-19 |
Family
ID=43902575
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13106474.7A HK1178804A1 (en) | 2009-12-08 | 2013-06-03 | Improved methods and compositions for vein harvest and autografting |
HK15111461.0A HK1210703A1 (en) | 2009-12-08 | 2015-11-20 | Improved methods and compositions for vein harvest and autografting |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15111461.0A HK1210703A1 (en) | 2009-12-08 | 2015-11-20 | Improved methods and compositions for vein harvest and autografting |
Country Status (11)
Country | Link |
---|---|
US (3) | US8691556B2 (fr) |
EP (2) | EP2509609B1 (fr) |
JP (2) | JP5819846B2 (fr) |
CN (2) | CN102834102B (fr) |
AU (1) | AU2010328203B2 (fr) |
CA (1) | CA2783236C (fr) |
DK (2) | DK2509609T3 (fr) |
ES (2) | ES2524549T3 (fr) |
HK (2) | HK1178804A1 (fr) |
SG (1) | SG182261A1 (fr) |
WO (1) | WO2011072012A2 (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8409846B2 (en) | 1997-09-23 | 2013-04-02 | The United States Of America As Represented By The Department Of Veteran Affairs | Compositions, methods and devices for maintaining an organ |
US8304181B2 (en) | 2004-10-07 | 2012-11-06 | Transmedics, Inc. | Method for ex-vivo organ care and for using lactate as an indication of donor organ status |
US9301519B2 (en) | 2004-10-07 | 2016-04-05 | Transmedics, Inc. | Systems and methods for ex-vivo organ care |
IL273422B (en) | 2004-10-07 | 2022-07-01 | Transmedics Inc | Methods and systems for extracorporeal organ treatment |
US9078428B2 (en) | 2005-06-28 | 2015-07-14 | Transmedics, Inc. | Systems, methods, compositions and solutions for perfusing an organ |
US9457179B2 (en) | 2007-03-20 | 2016-10-04 | Transmedics, Inc. | Systems for monitoring and applying electrical currents in an organ perfusion system |
US9462802B2 (en) | 2008-01-31 | 2016-10-11 | Transmedics, Inc. | Systems and methods for ex vivo lung care |
US9554826B2 (en) | 2008-10-03 | 2017-01-31 | Femasys, Inc. | Contrast agent injection system for sonographic imaging |
EP3178422B1 (fr) * | 2010-11-09 | 2019-06-12 | Femasys Inc. | Dispositifs de gestion de pression de fluide |
EP4032401A1 (fr) * | 2011-04-14 | 2022-07-27 | Transmedics, Inc. | Solution ocs pour perfusion ex vivo de greffons pulmonaires |
US9173718B2 (en) * | 2013-03-27 | 2015-11-03 | Terumo Cardiovascular Systems Corporation | Blood vessel marking system |
WO2014182601A1 (fr) | 2013-05-08 | 2014-11-13 | Children's Medical Center Corporation | Procédé de prévention et de traitement de diabète de type 1, rejet d'allogreffe et fibrose pulmonaire (par ciblage de l'axe atp/p2x7r) |
WO2015051336A1 (fr) | 2013-10-03 | 2015-04-09 | David Wise | Compositions et procédés pour le traitement de la douleur pelvienne et d'autres états douloureux |
ES2839202T3 (es) | 2014-06-02 | 2021-07-05 | Transmedics Inc | Sistema de cuidado de órganos ex vivo |
US11083191B2 (en) | 2014-12-12 | 2021-08-10 | Tevosol, Inc. | Apparatus and method for organ perfusion |
US20180290979A1 (en) * | 2015-04-30 | 2018-10-11 | Kyoto University | Composition having compound accelerating phosphorylation of ampk as effective component |
IL310004A (en) | 2015-09-09 | 2024-03-01 | Transmedics Inc | A tube and a catheter for a system to treat organs outside the body |
US11628239B2 (en) | 2016-11-04 | 2023-04-18 | University Of Delaware | Method for protecting skeletonized blood vessels |
WO2019018470A1 (fr) | 2017-07-18 | 2019-01-24 | Obp Medical Corporation | Acte à effraction minimale sans contact (mint) pour prélever la grande veine saphène (gsv) et hydrodissecteur et écarteur veineux destinés à être utilisés pendant l'acte à mint |
CN107912419A (zh) * | 2017-10-11 | 2018-04-17 | 重庆金时代生物技术有限公司 | 一种人外周血单个核细胞的冻存液及冻存方法 |
JP7036670B2 (ja) * | 2018-05-31 | 2022-03-15 | アークレイ株式会社 | 血液中の稀少細胞検査、該検査ための血液処理方法及び採血管 |
KR102319110B1 (ko) * | 2021-07-12 | 2021-10-29 | 주식회사 이노스템바이오 | 세포성 바이오 의약품의 장기 보존을 위한 동결보존액 조성물 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US716246A (en) | 1902-03-24 | 1902-12-16 | Fletcher Raymond | Excavating apparatus. |
US872525A (en) | 1905-02-27 | 1907-12-03 | Henry F Loewer | Last. |
DE4427299A1 (de) * | 1994-08-02 | 1996-02-08 | Faber Castell A W | Beize und Verfahren zum Färben von Holz |
EP1281357A3 (fr) * | 1997-09-26 | 2003-07-09 | Duke University | Cathéter et méthodes de perfusion-occlusion |
SE9904652D0 (sv) * | 1999-12-17 | 1999-12-17 | Astra Pharma Prod | Novel Compounds |
US6608038B2 (en) * | 2000-03-15 | 2003-08-19 | Novartis Ag | Methods and compositions for treatment of diabetes and related conditions via gene therapy |
US20020182646A1 (en) | 2001-04-30 | 2002-12-05 | Ke Huazhu | Methods and products for identifying modulators of P2X7 receptor activity, and their use in the treatment of skeletal disorders |
US20130136725A1 (en) * | 2002-06-19 | 2013-05-30 | Nuevas Alternativas Naturales Thermafat, S.A.P.I. De C.V. | Compositions for systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance |
GB0324498D0 (en) | 2003-07-21 | 2003-11-26 | Aventis Pharma Inc | Heterocyclic compounds as P2X7 ion channel blockers |
WO2005019182A1 (fr) * | 2003-08-20 | 2005-03-03 | Bayer Healthcare Ag | Derives de pyrazolylmethylbenzamide utilises comme antagonistes du recepteur p2xt |
SE0302488D0 (sv) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | New combination |
US7241776B2 (en) * | 2004-08-02 | 2007-07-10 | Abbott Laboratories | Cyanoamidine P2X7 antagonists for the treatment of pain |
EP1789551A2 (fr) | 2004-08-31 | 2007-05-30 | Sylentis S.A.U. | Procedes et compositions permettant d'inhiber l'expression du recepteur p2x7 |
US8440610B2 (en) * | 2004-11-12 | 2013-05-14 | Massachusetts Institute Of Technology | Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells |
EP1885376A1 (fr) | 2005-05-05 | 2008-02-13 | Medicure International Inc. | Inhibition des voies dependantes de p2x7 mediees par l'atp au moyen de pyridoxal-5-phosphate et de composes associes a la vitamine b6 |
WO2007002139A2 (fr) * | 2005-06-22 | 2007-01-04 | The Trustees Of The University Of Pennsylvania | Neuroprotection de cellules ganglionnaires de la retine |
EP1951689A1 (fr) | 2005-11-07 | 2008-08-06 | Abbott Laboratories | Antagonistes des recepteurs p2x7 et methodes d'utilisation |
US20070122849A1 (en) | 2005-11-29 | 2007-05-31 | Peekhaus Norbert T | Rhesus monkey P2X7 purinergic receptor and uses thereof |
WO2007070301A2 (fr) * | 2005-12-05 | 2007-06-21 | Regeneration Technologies, Inc. | Stérilisation et décellularisation de greffe vasculaire |
US7597496B2 (en) * | 2006-05-16 | 2009-10-06 | Dubinski Jonathan B | Scent activated, memory enhancing memory stick system |
GB0611154D0 (en) | 2006-06-06 | 2006-07-19 | Glaxo Group Ltd | Novel receptor antagonists and their methods of use |
WO2007141267A1 (fr) | 2006-06-06 | 2007-12-13 | Glaxo Group Limited | Dérivés de n- (phénylméthyl) -2- (1h-pyraz0l-4-yl) acétamide utilisés comme antagonistes fp2x7 pour le traitement de la douleur, de l'inflammation et de la neurodégénérescence |
SI2049478T1 (sl) | 2006-07-06 | 2012-08-31 | Glaxo Group Ltd | Substituirani N-fenilmetil-5-okso-prolin-2-amidi kot antagonisti receptorja P2X7 in postopki za njihovo uporabo |
EP2063873A2 (fr) | 2006-08-31 | 2009-06-03 | Horizon Therapeutics, Inc. | Formulations à dose unique d'ains avec antagonistes du récepteur de h2, et procédés d'utilisation |
WO2008043145A1 (fr) | 2006-10-10 | 2008-04-17 | Biosceptre International Limited | Hybridomes produisant des anticorps dirigés contre le récepteur p2x7 non fonctionnel |
WO2008043146A1 (fr) * | 2006-10-10 | 2008-04-17 | Biosceptre International Limited | Anticorps contre le récepteur p2x7 non fonctionnel |
US8141551B2 (en) * | 2007-02-16 | 2012-03-27 | Destal Industries, Inc. | Mouthpiece and flow rate controller for intrapulmonary delivery devices |
US20080221027A1 (en) * | 2007-03-09 | 2008-09-11 | The Regents Of The University Of California | Composition and Methods for the Treatment of Duchene Muscular Dystrophy |
CN103497185A (zh) * | 2007-03-14 | 2014-01-08 | 兰贝克赛实验室有限公司 | 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物 |
GB0705882D0 (en) | 2007-03-27 | 2007-05-02 | Glaxo Group Ltd | Novel compounds |
WO2008116845A1 (fr) | 2007-03-28 | 2008-10-02 | Glaxo Group Limited | Dérivés pipéridone carboxamide comme modulateurs du p2x7 |
JP2010522710A (ja) | 2007-03-29 | 2010-07-08 | グラクソ グループ リミテッド | P2x7調節因子としてのオキサゾリジンおよびモルホリンカルボキサミド誘導体 |
JP2010523524A (ja) | 2007-04-03 | 2010-07-15 | グラクソ グループ リミテッド | P2x7調節因子としてのイミダゾリジンカルボキサミド誘導体 |
JP2010523623A (ja) | 2007-04-11 | 2010-07-15 | グラクソ グループ リミテッド | P2x7調節因子としてのピラゾール誘導体 |
RU2010121763A (ru) | 2007-10-31 | 2011-12-10 | Ниссан Кемикал Индастриз, Лтд. (Jp) | Производные пиридазинона и ингибиторы р2х7 рецептора |
GB0724625D0 (en) | 2007-12-18 | 2008-01-30 | Glaxo Group Ltd | Novel compounds |
BRPI0822058A2 (pt) | 2007-12-18 | 2015-06-23 | Glaxo Group Ltd | Derivados de 5-oxo-3-pirrolidinacarboxamida como moduladores de p2x7 |
CA2656577A1 (fr) * | 2008-04-14 | 2009-10-14 | The University Of British Columbia | Methode pour evaluer un cancer |
US8846068B2 (en) * | 2008-04-18 | 2014-09-30 | Warsaw Orthopedic, Inc. | Methods and compositions for treating post-operative pain comprising a local anesthetic |
JP2011525550A (ja) * | 2008-06-23 | 2011-09-22 | 広州康采恩医薬有限公司 | 肺癌治療用デキストラン |
BRPI0923488A2 (pt) | 2008-12-23 | 2019-09-24 | Hoffmann La Roche | amidas de didropiridona como modulares p2x7 |
US8153808B2 (en) | 2008-12-23 | 2012-04-10 | Roche Palo Alto Llc | Dihydropyridone amides as P2X7 modulators |
KR101381074B1 (ko) | 2008-12-23 | 2014-04-11 | 에프. 호프만-라 로슈 아게 | P2x7 조절제로서의 디히드로피리돈 아미드 |
CN102264701A (zh) | 2008-12-23 | 2011-11-30 | 霍夫曼-拉罗奇有限公司 | 作为p2x7调节剂的二氢吡啶酮脲 |
EP2382202A1 (fr) | 2008-12-23 | 2011-11-02 | F. Hoffmann-La Roche AG | Amides de dihydropyridone comme modulateurs de p2x7 |
BR102012009350B1 (pt) * | 2012-04-20 | 2020-12-29 | Biolab Sanus Farmacêutica Ltda | composição farmacêutica tópica, processo de produção da composição farmacêutica tópica e uso da composição farmacêutica tópica |
-
2010
- 2010-12-08 DK DK10807761.1T patent/DK2509609T3/da active
- 2010-12-08 AU AU2010328203A patent/AU2010328203B2/en not_active Ceased
- 2010-12-08 CN CN201080055389.XA patent/CN102834102B/zh not_active Expired - Fee Related
- 2010-12-08 ES ES10807761.1T patent/ES2524549T3/es active Active
- 2010-12-08 SG SG2012042677A patent/SG182261A1/en unknown
- 2010-12-08 CA CA2783236A patent/CA2783236C/fr not_active Expired - Fee Related
- 2010-12-08 ES ES14181978T patent/ES2710522T3/es active Active
- 2010-12-08 EP EP10807761.1A patent/EP2509609B1/fr not_active Not-in-force
- 2010-12-08 JP JP2012543244A patent/JP5819846B2/ja not_active Expired - Fee Related
- 2010-12-08 US US12/963,375 patent/US8691556B2/en active Active
- 2010-12-08 EP EP14181978.9A patent/EP2848256B1/fr not_active Not-in-force
- 2010-12-08 CN CN201410779180.8A patent/CN104623665B/zh not_active Expired - Fee Related
- 2010-12-08 DK DK14181978.9T patent/DK2848256T3/en active
- 2010-12-08 WO PCT/US2010/059459 patent/WO2011072012A2/fr active Application Filing
-
2013
- 2013-06-03 HK HK13106474.7A patent/HK1178804A1/xx not_active IP Right Cessation
-
2014
- 2014-02-25 US US14/188,993 patent/US10531654B2/en not_active Expired - Fee Related
-
2015
- 2015-10-01 JP JP2015195779A patent/JP6203223B2/ja not_active Expired - Fee Related
- 2015-11-20 HK HK15111461.0A patent/HK1210703A1/xx not_active IP Right Cessation
-
2016
- 2016-09-27 US US15/277,843 patent/US10149470B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2710522T3 (es) | 2019-04-25 |
EP2848256B1 (fr) | 2018-11-14 |
CN104623665A (zh) | 2015-05-20 |
US20140220547A1 (en) | 2014-08-07 |
EP2848256A3 (fr) | 2015-09-30 |
DK2509609T3 (da) | 2014-11-10 |
SG182261A1 (en) | 2012-08-30 |
WO2011072012A2 (fr) | 2011-06-16 |
US10149470B2 (en) | 2018-12-11 |
US20170071192A1 (en) | 2017-03-16 |
JP6203223B2 (ja) | 2017-09-27 |
US20110190572A1 (en) | 2011-08-04 |
CN102834102B (zh) | 2015-01-14 |
CA2783236C (fr) | 2020-03-10 |
HK1210703A1 (en) | 2016-05-06 |
JP2013512968A (ja) | 2013-04-18 |
US8691556B2 (en) | 2014-04-08 |
AU2010328203B2 (en) | 2014-05-15 |
EP2848256A2 (fr) | 2015-03-18 |
JP2016094386A (ja) | 2016-05-26 |
DK2848256T3 (en) | 2019-03-04 |
EP2509609A2 (fr) | 2012-10-17 |
CN104623665B (zh) | 2018-01-12 |
US10531654B2 (en) | 2020-01-14 |
ES2524549T3 (es) | 2014-12-10 |
JP5819846B2 (ja) | 2015-11-24 |
CA2783236A1 (fr) | 2011-06-16 |
WO2011072012A3 (fr) | 2011-09-09 |
CN102834102A (zh) | 2012-12-19 |
AU2010328203A1 (en) | 2012-07-05 |
EP2509609B1 (fr) | 2014-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1210703A1 (en) | Improved methods and compositions for vein harvest and autografting | |
HRP20171870T1 (hr) | Sastavi i postupci za ubrzavanje rasta mišića | |
FI3812360T3 (fi) | Monoklooritrifluoripropeeniyhdisteitä ja -koostumuksia ja niitä käyttäviä menetelmiä | |
ZA201102765B (en) | Process for extracting cardiac glycodides and compositions | |
GB201010580D0 (en) | Machine dishwashing compositions and methods | |
EP2629742A4 (fr) | Compositions de revitalisation capillaire et méthodes associées | |
IL218212A0 (en) | Therapeutic methods and compositions | |
EP2429584A4 (fr) | Procédés et compositions de traitement | |
HK1215025A1 (zh) | 純化的吡咯並喹啉基-吡咯烷- -二酮組合物和用於製備且使用其的方法 | |
SI2315597T1 (sl) | Novi sestavki in postopki | |
LT2437606T (lt) | Kompozicijos ir būdai skirti didinti telomerazės aktyvumą | |
EP2294199A4 (fr) | Compositions et procédés pour améliorer des plantes | |
GB0903299D0 (en) | Composition and methods | |
EP2515940A4 (fr) | Compositions immunogènes et méthodes correspondantes | |
EP2642854A4 (fr) | Compositions fongicides et procédés | |
EP2512483A4 (fr) | Compositions de balaglitazone et méthodes associées | |
HK1168025A1 (en) | Compositions and methods for enhancing eyelashes | |
HK1201451A1 (en) | Compositions and methods | |
GB201018650D0 (en) | Methods and compositions | |
GB0901494D0 (en) | Compositions and Methods | |
PL2328402T3 (pl) | Sposoby i kompozycje do wydłużenia okresu przechowywania owoców | |
EP2461870A4 (fr) | Compositions thérapeutiques et procédés associés | |
EP2488624A4 (fr) | Compositions stabilisées tensio-actif - oxydant et procédés correspondants | |
GB0903913D0 (en) | Compositions and methods | |
GB0908498D0 (en) | Compositions and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20211208 |